Otsuka has claimed FDA approval for its IgA nephropathy (IgAN) therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch. Anti-APRIL antibody Voyxact ...
The latest edition of The Greg Cote Show, Episode 318, is out now! It’s another never-know-what’s-next variety show with even more curves than usual because myself and boy Christopher are side by side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results